Overall, the results from both analyses raise the possibility that combined effects of candidate genes, CHEK1, ETS1, LEF1, TIMP1, and CXCL10, might lead to increased MMP9 levels that can potentially be detrimental to the structural integrity of the SGs in patients with SS. This evidence concerns the gene CXCL10 and synovial sarcoma.